Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CDH11 expression is associated with survival in patients with osteosarcoma.
Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San Julian M, Lecanda F, Sierrasesumaga L, Müller C, Fodstad O, Ju J. Nakajima G, et al. Among authors: lecanda f. Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):37-42. Cancer Genomics Proteomics. 2008. PMID: 18359978 Free article.
ENPP1 Immunobiology as a Therapeutic Target.
Ruiz-Fernández de Córdoba B, Martínez-Monge R, Lecanda F. Ruiz-Fernández de Córdoba B, et al. Among authors: lecanda f. Clin Cancer Res. 2023 Jun 13;29(12):2184-2193. doi: 10.1158/1078-0432.CCR-22-1681. Clin Cancer Res. 2023. PMID: 36719675 Free PMC article. Review.
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A, Zalacain M, Folio C, Zandueta C, Sierrasesúmaga L, San Julián M, Toledo G, De Las Rivas J, Lecanda F. Patiño-García A, et al. Among authors: lecanda f. Clin Cancer Res. 2009 Aug 15;15(16):5082-91. doi: 10.1158/1078-0432.CCR-09-0300. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671856 Free article.
Genome-wide association study identifies two susceptibility loci for osteosarcoma.
Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Kurucu N, Ilhan IE, Sari N, Serra M, Hattinger C, Picci P, Spector LG, Barkauskas DA, Marina N, de Toledo SR, Petrilli AS, Amary MF, Halai D, Thomas DM, Douglass C, Meltzer PS, Jacobs K, Chung CC, Berndt SI, Purdue MP, Caporaso NE, Tucker M, Rothman N, Landi MT, Silverman DT, Kraft P, Hunter DJ, Malats N, Kogevinas M, Wacholder S, Troisi R, Helman L, Fraumeni JF Jr, Yeager M, Hoover RN, Chanock SJ. Savage SA, et al. Among authors: lecanda f. Nat Genet. 2013 Jul;45(7):799-803. doi: 10.1038/ng.2645. Epub 2013 Jun 2. Nat Genet. 2013. PMID: 23727862 Free PMC article.
The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity.
Martinez-Velez N, Xipell E, Jauregui P, Zalacain M, Marrodan L, Zandueta C, Vera B, Urquiza L, Sierrasesúmaga L, Julián MS, Toledo G, Fueyo J, Gomez-Manzano C, Torre W, Lecanda F, Patiño-García A, Alonso MM. Martinez-Velez N, et al. Among authors: lecanda f. J Bone Miner Res. 2014 Oct;29(10):2287-96. doi: 10.1002/jbmr.2253. J Bone Miner Res. 2014. PMID: 24737304 Free article.
88 results